Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral formulation for oral use. It is employed to support cognitive function and neurological recovery in adults with conditions such as dementia, post‑stroke deficits, myoclonus, vertigo, and learning difficulties.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide across Europe, Asia, Africa and the Americas. The company adheres to stringent quality standards and ensures reliable logistics for each shipment.

Nootropil (piracetam) is indicated for several neurological conditions where it may enhance cognitive performance and neuronal function. - Cognitive impairment and dementia: may improve memory, attention and overall cognitive abilities in affected individuals. - Post‑stroke recovery: supports rehabilitation by enhancing neuroplasticity and cerebral blood flow after cerebrovascular events. - Myoclonus and movement disorders: reduces frequency and severity of involuntary muscle jerks. - Vertigo and balance disorders: helps alleviate dizziness by stabilizing vestibular function. - Dyslexia and learning difficulties: may aid learning processes and reading skills in patients with developmental challenges.

Piracetam is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Nervousness or agitation: feelings of restlessness or increased anxiety. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Insomnia: difficulty initiating or maintaining sleep. - Dizziness: sensation of lightheadedness, especially on standing. - Fatigue: unusual tiredness or lack of energy.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema requiring medical attention. - Hematologic changes: rare cases of thrombocytopenia or leukopenia.

When prescribing or dispensing Piracetam, several precautions should be observed to ensure safe use. - Renal function: assess kidney performance, as impaired clearance may increase exposure. - Hepatic function: monitor liver status in patients with severe liver disease. - Elderly patients: start with lower doses and observe for tolerance. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: avoid use unless benefits clearly outweigh potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Piracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Anticoagulants: may enhance anticoagulant effect, increasing bleeding risk. - Anticonvulsants (e.g., carbamazepine): may reduce piracetam plasma levels, diminishing therapeutic effect.

Moderate Interactions (Monitor Closely): - Caffeine-containing products: can potentiate nervous system stimulation, leading to jitteriness. - Diuretics: may alter electrolyte balance, affecting neuronal stability. - Alcohol: combined use may increase central nervous system side effects.